Walmart halts H-1B visa offers amid Trump’s $100,000 fee increase - Bloomberg
Investing.com - Benchmark lowered its price target on Semler Scientific (NASDAQ:SMLR) to $86.00 from $101.00 on Tuesday while maintaining a Buy rating on the stock. The company, currently trading at $32.06, maintains impressive gross profit margins of 90.84% and trades at a P/E ratio of 8.31, according to InvestingPro data.
The price target adjustment follows Semler Scientific’s announcement that it has agreed to be acquired by Strive, Inc. (NASDAQ:ASST) in an all-stock transaction.
Benchmark analyst Mark Palmer indicated the deal "appears to have rung the opening bell for consolidation in the corporate bitcoin treasury space."
The firm suggested that while the market evaluates the longer-term implications of the transaction, Semler Scientific shares currently represent an investment opportunity.
Semler Scientific is being acquired by Strive, Inc., though specific terms of the all-stock deal were not detailed in the announcement.
In other recent news, Semler Scientific Inc. reported a significant earnings beat for the second quarter of 2025. The company posted earnings per share of $5.04, far exceeding the projected loss of $0.22. Revenue also surpassed expectations, coming in at $8.22 million compared to the forecasted $8.1 million. Additionally, Semler Scientific has entered into a definitive agreement for an all-stock acquisition by Strive Inc., valuing Semler at a 210% premium over its previous closing price. As part of this deal, each Semler common share will be exchanged for 21.05 Class A common shares of Strive. Shareholders of Semler recently approved an increase in shares but rejected a preferred stock proposal. Cantor Fitzgerald reiterated its Overweight rating on Semler Scientific, slightly adjusting the price target to $60.00. These recent developments reflect a period of significant activity for Semler Scientific.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.